Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Sigma Healthcare Ltd ( (AU:SIG) ) has issued an announcement.
Sigma Healthcare Ltd’s Annual Report for 2024/25 outlines the company’s financial performance, operational highlights, and strategic initiatives. The report provides insights into Sigma’s efforts to strengthen its market position through business acquisitions and enhanced financial management. It also highlights the company’s commitment to maintaining robust financial health and delivering value to its stakeholders.
The most recent analyst rating on (AU:SIG) stock is a Buy with a A$3.45 price target. To see the full list of analyst forecasts on Sigma Healthcare Ltd stock, see the AU:SIG Stock Forecast page.
More about Sigma Healthcare Ltd
Sigma Healthcare Ltd operates in the healthcare industry, providing pharmaceutical distribution and related services. The company focuses on supplying a wide range of healthcare products and services to community pharmacies, hospitals, and other healthcare providers across Australia.
Average Trading Volume: 34,314,772
Technical Sentiment Signal: Buy
Current Market Cap: A$35.14B
Learn more about SIG stock on TipRanks’ Stock Analysis page.